Esbriet Distribution

Authorized Specialty Distributors and Specialty Pharmacies

Esbriet Access Solutions works with specialty pharmacies (SPs) to help patients receive their medicines.

An SP may provide the following services:

  • Reimbursement resources
  • Clinical services to support patients throughout their treatment
  • The ability to manage the specialty handling and shipping needs linked with many specialty therapies

You can work with your preferred SP or contact Esbriet Access Solutions to learn which SP the patient’s health insurance plan requires.

Distributor Telephone Fax Web Orders
Dakota Drug 866-210-5887 763-421-0661 www.dakdrug.com/ddos/
DMS Pharmaceutical 877-788-1100 847-518-1105 dmspharma.com/store.htm
McKesson Specialty Health 800-482-6700 800-289-9285 mscs.mckesson.com

 

Distributor Telephone Fax Web Orders
ASD Healthcare 800-746-6273 800-547-9413 N/A
Cardinal Health Specialty Distribution 800-926-3161 888-345-4916 specialtysolutions.cardinalhealth.com
McKesson Specialty Health 800-482-6700 800-289-9285 mscs.mckesson.com

 

Distributor Telephone Fax Web Orders
Humana Specialty Pharmacy
800-486-2668
877-405-7940
www.humanapharmacy.com/specialty
Specialty Pharmacies 800-551-2231 N/A N/A

 

Distributor Telephone Fax Web Orders
Absolute Pharmacy Care 787-892-8700
787-264-5800 www.absolutepharmacypr.com/
Axium Healthcare Pharmacy 767-780-7200 787-779-1430
1-800-546-2163
www.axiumpr.com
Cardinal Health Puerto Rico 800-981-4699 787-625-4398 cardinalhealth.pr
Special Care Pharmacy Services 787-783-8579
787-781-4585
888-727-1727
787-783-2951
787-706-0405
888-341-1586
www.scpspr.com/
Specialty Pharmacy Services (SPS) 787-704-2025 787-704-2027 www.spscaguas.com/

 

Distributor Telephone Fax Web Orders
Accredo Specialty Pharmacy 866-206-5015 888-302-1028 www.accredo.com
Acro Pharmaceutical Services 800-906-7798 855-439-4768
www.acropharmacy.com
Advanced Care Scripts 866-681-7131 866-679-7131 www.omnicarescg.com/omnicarescg/
acs
Aetna Specialty Pharmacy 866-782-2779
866-329-2779
https://www.aetna.com/individuals-families/pharmacy/specialty-pharmacy.html
AllianceRx Walgreens Prime
888-347-3416 877-231-8302
https://www.alliancerxwp.com
BriovaRx 800-850-9122 800-218-3221 www.briovarx.com
Cigna Specialty Pharmacy 800-351-3606 800-351-3616 www.cignaforhcp.com
CVS/Specialty 800-237-2767 800-323-2445 www.cvsspecialty.com
Diplomat Specialty Pharmacy 877-977-9118 800-550-6272 www.diplomatpharmacy.com
Humana Specialty Pharmacy 800-486-2668 877-405-7940 www.humana.com
IngenioRX 888-288-2011 888-263-2871 N/A
Kroger Specialty Pharmacy 855-274-1694 855-819-6922 www.krogerspecialtypharmacy.com
Orsini Healthcare 800-355-9366 877-358-9246 www.orsinihealthcare.com
Perform Specialty
855-287-7888
844-489-9565
www.performspecialty.com

Genentech does not influence or advocate the use of any one specialty distributor or specialty pharmacy. We make no representation or guarantee of service or coverage of any item.

Important Safety Information & Indication

Indication

Esbriet® (pirfenidone) is indicated for the treatment of idiopathic pulmonary fibrosis (IPF).

Select Important Safety Information

Elevated liver enzymes: ALT, AST, and bilirubin elevations have occurred with Esbriet. Monitor ALT, AST, and bilirubin before and during treatment. Temporary dosage reductions or discontinuations may be required.

Photosensitivity reaction or rash: Photosensitivity and rash have been noted with Esbriet. Avoid exposure to sunlight and sunlamps, and concomitant medications known to cause photosensitivity. Wear sunscreen and protective clothing daily. Temporary dosage reductions or discontinuations may be required.

Gastrointestinal disorders: Nausea, vomiting, diarrhea, dyspepsia, gastroesophageal reflux disease (GERD), and abdominal pain have occurred with Esbriet. Temporary dosage reductions or discontinuations may be required

Adverse reactions: The most common adverse reactions (≥10%) are nausea, rash, abdominal pain, upper respiratory tract infection, diarrhea, fatigue, headache, dyspepsia, dizziness, vomiting, anorexia, GERD, sinusitis, insomnia, weight decreased, and arthralgia.

Drug interactions: Moderate (e.g., ciprofloxacin) and strong (e.g., fluvoxamine) CYP1A2 inhibitors increase systemic exposure of Esbriet and may alter its adverse reaction profile. If discontinuation of strong CYP1A2 inhibitors and/or high-dose ciprofloxacin prior to starting Esbriet is not possible, dosage reductions of Esbriet are recommended.

Specific populations: 

Hepatic impairment: Monitor for adverse reactions and consider dosage modification or discontinuation of Esbriet as needed. Esbriet is not recommended for use in patients with severe hepatic impairment.

Renal impairment: Monitor for adverse reactions and consider dosage modification or discontinuation of Esbriet as needed. Esbriet is not recommended for use in patients with end-stage renal disease requiring dialysis.

Smokers: Decreased exposure has been noted in smokers which may alter the efficacy profile of Esbriet.

You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at 1-888-835-2555.

Please see full Prescribing Information for additional important safety information at esbriet.com.